Literature DB >> 15182606

Use of the early invasive approach in the management of acute coronary syndromes.

Jorge F Saucedo1, Thomas A Hennebry.   

Abstract

Large randomized clinical trials of early invasive versus conservative strategy in patients with non-ST-elevation acute coronary syndromes (NSTE ACS) have been published recently. These studies have clearly shown that intermediate and high-risk patients presenting with NSTE ACS have better outcomes when referred early to cardiac catheterization. Patients who are referred early to cardiac catheterization have a reduction of death, myocardial infarction, and recurrent ischemia, and also have shorter hospital stays. Guidelines recommend referral to cardiac catheterization for intermediate and high-risk NSTE ACS patients within the first 48 hours of presentation. Despite these recommendations, data from a large nationwide registry show that the majority of high-risk patients with NSTE ACS are not being managed with an early invasive strategy.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15182606     DOI: 10.1007/s11886-004-0078-8

Source DB:  PubMed          Journal:  Curr Cardiol Rep        ISSN: 1523-3782            Impact factor:   2.931


  11 in total

1.  Comparison of early invasive and conservative strategies in patients with unstable coronary syndromes treated with the glycoprotein IIb/IIIa inhibitor tirofiban.

Authors:  C P Cannon; W S Weintraub; L A Demopoulos; R Vicari; M J Frey; N Lakkis; F J Neumann; D H Robertson; P T DeLucca; P M DiBattiste; C M Gibson; E Braunwald
Journal:  N Engl J Med       Date:  2001-06-21       Impact factor: 91.245

2.  Outcome at 1 year after an invasive compared with a non-invasive strategy in unstable coronary-artery disease: the FRISC II invasive randomised trial. FRISC II Investigators. Fast Revascularisation during Instability in Coronary artery disease.

Authors:  L Wallentin; B Lagerqvist; S Husted; F Kontny; E Ståhle; E Swahn
Journal:  Lancet       Date:  2000-07-01       Impact factor: 79.321

3.  Invasive compared with non-invasive treatment in unstable coronary-artery disease: FRISC II prospective randomised multicentre study. FRagmin and Fast Revascularisation during InStability in Coronary artery disease Investigators.

Authors: 
Journal:  Lancet       Date:  1999-08-28       Impact factor: 79.321

4.  Factors associated with failure of medical therapy in patients with unstable angina and non-Q wave myocardial infarction. A TIMI-IIIB database study.

Authors:  P H Stone; B Thompson; B L Zaret; B Chaitman; R S Gibson; M J Schweiger; R Steingart; J Kirshenbaum; C Thompson; A Fung; C H McCabe; G L Knatterud; E Braunwald
Journal:  Eur Heart J       Date:  1999-08       Impact factor: 29.983

5.  Use of risk stratification to identify patients with unstable angina likeliest to benefit from an invasive versus conservative management strategy.

Authors:  D H Solomon; P H Stone; R J Glynn; D A Ganz; C M Gibson; R Tracy; J Avorn
Journal:  J Am Coll Cardiol       Date:  2001-10       Impact factor: 24.094

6.  Interventional versus conservative treatment for patients with unstable angina or non-ST-elevation myocardial infarction: the British Heart Foundation RITA 3 randomised trial. Randomized Intervention Trial of unstable Angina.

Authors:  K A A Fox; P A Poole-Wilson; R A Henderson; T C Clayton; D A Chamberlain; T R D Shaw; D J Wheatley; S J Pocock
Journal:  Lancet       Date:  2002-09-07       Impact factor: 79.321

7.  ACC/AHA guideline update for the management of patients with unstable angina and non-ST-segment elevation myocardial infarction--2002: summary article: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on the Management of Patients With Unstable Angina).

Authors:  Eugene Braunwald; Elliott M Antman; John W Beasley; Robert M Califf; Melvin D Cheitlin; Judith S Hochman; Robert H Jones; Dean Kereiakes; Joel Kupersmith; Thomas N Levin; Carl J Pepine; John W Schaeffer; Earl E Smith; David E Steward; Pierre Theroux; Raymond J Gibbons; Joseph S Alpert; David P Faxon; Valentin Fuster; Gabriel Gregoratos; Loren F Hiratzka; Alice K Jacobs; Sidney C Smith
Journal:  Circulation       Date:  2002-10-01       Impact factor: 29.690

8.  Application of current guidelines to the management of unstable angina and non-ST-elevation myocardial infarction.

Authors:  Eugene Braunwald
Journal:  Circulation       Date:  2003-10-21       Impact factor: 29.690

9.  Effects of tissue plasminogen activator and a comparison of early invasive and conservative strategies in unstable angina and non-Q-wave myocardial infarction. Results of the TIMI IIIB Trial. Thrombolysis in Myocardial Ischemia.

Authors: 
Journal:  Circulation       Date:  1994-04       Impact factor: 29.690

10.  Outcomes in patients with acute non-Q-wave myocardial infarction randomly assigned to an invasive as compared with a conservative management strategy. Veterans Affairs Non-Q-Wave Infarction Strategies in Hospital (VANQWISH) Trial Investigators.

Authors:  W E Boden; R A O'Rourke; M H Crawford; A S Blaustein; P C Deedwania; R G Zoble; L F Wexler; R E Kleiger; C J Pepine; D R Ferry; B K Chow; P W Lavori
Journal:  N Engl J Med       Date:  1998-06-18       Impact factor: 91.245

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.